Muscle-Invasive Urothelial Carcinoma of the Bladder: Neoadjuvant Chemotherapy Enables Organ-Preserving Therapy in Carefully Selected Patients
- 13 February 2008
- journal article
- editorial
- Published by Elsevier in European Urology
- Vol. 54 (1) , 21-23
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Outcome of Patients Who Refuse Cystectomy after Receiving Neoadjuvant Chemotherapy for Muscle-Invasive Bladder CancerEuropean Urology, 2008
- Association of Procedure Volume With Radical Cystectomy Outcomes in a Nationwide DatabaseJournal of Urology, 2007
- Nerve-Sparing Radical Cystectomy and Orthotopic Bladder Replacement in Female PatientsEuropean Urology, 2007
- Clinical Indications and Outcomes with Nerve-sparing Cystectomy in Patients with Bladder CancerUrologic Clinics of North America, 2005
- Organ Conservation in Invasive Bladder Cancer by Transurethral Resection, Chemotherapy and Radiation: Results of a Urodynamic and Quality of Life Study on Long-term SurvivorsJournal of Urology, 2003
- Maintenance Bacillus Calmette-Guerin for Ta T1 Bladder Tumors Is Not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III TrialEuropean Urology, 2003
- Can patient selection for bladder preservation be based on response to chemotherapy?Cancer, 2003
- Combined-Modality Treatment and Selective Organ Preservation in Invasive Bladder Cancer: Long-Term ResultsJournal of Clinical Oncology, 2002
- Grading and Staging of Bladder Carcinoma in Transurethral Resection SpecimensAmerican Journal of Clinical Pathology, 2000
- Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome.Journal of Clinical Oncology, 1998